1-7 of 7
Michael E. Roth
Close
Sort by
Journal Articles

Comparison of Overall Survival Among Adolescents and Young Adults (AYA) with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL) Treated with Pediatric-Inspired or Non-Pediatric Inspired Regimens: A Real-World Analysis Using Claims Data

Tarun Bhagnani, Jian J. Zhu, David Robert R. Freyer, Kristen M. O'Dwyer, Michael E. Roth, Julie A. Wolfson, Qian Meng, Rui Sammi Tang, Robert G. Paglia
Journal: Blood
Blood (2022) 140 (Supplement 1): 2190–2192.
https://doi.org/10.1182/blood-2022-162681
Published: 2022
Journal Articles

Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration

Adriana Trabal, Amber Gibson, David McCall, Kris M Mahadeo, Laurie Toepfer, Michael E. Roth, Meridith Buzbee, Tapan M. Kadia, Sofia Garces, Marina Konopleva, Courtney D. DiNardo, Naval Daver, Nicholas J. Short, Ghayas C. Issa, Farhad Ravandi, Cesar Nunez, Sajad J Khazal, Hana Paek, Julienne Brackett, Guillermo Garcia-Manero, Hagop Kantarjian, Andrea N Marcogliese, ZoAnn Dreyer, Michele S. Redell, Joanna S. Yi, Alexandra McLean Stevens, Branko Cuglievan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1247.
https://doi.org/10.1182/blood-2021-147379
Published: 2021
Journal Articles

DNMT3A Mutations Should be Considered in the Risk Stratification for Pediatric and Adolescent and Young Adult Patients with Acute Myeloid Leukemia

Dristhi Ragoonanan, Avis Harden, Amr Elgehiny, Cesar Nunez, Michael E. Roth, David McCall, Branko Cuglievan, Priti Tewari, Demetrios Petropoulos, Kris M Mahadeo, Sajad J Khazal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1308.
https://doi.org/10.1182/blood-2021-151043
Published: 2021
Journal Articles

A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children's Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients

Edoardo Pennesi, Erica Brivio, Marieke E. Willemse, Alwin D. R. Huitema, Saurabh Chandra, Ashwini Vijayakumar, Vincent H.J. Van Der Velden, H. Berna Beverloo, Chandra Durairaj, Andrea Viqueira, Antonella Ingrosso, Franco Locatelli, Jayashree Motwani, Jean-Pierre Bourquin, Francisco J. Bautista Sirvent, Carmelo Rizzari, Arnaud Petit, Donna Lancaster, Markus Metzler, Yves Bertrand, Laura Murillo-Sanjuán, Andrew J. Bukowkinski, Julie Krystal, Inge M. Van Der Sluis, Michael E. Roth, Harm Van Tinteren, Nobuko Hijiya, Christian M. Zwaan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2558.
https://doi.org/10.1182/blood-2021-145709
Published: 2021
Journal Articles

Evaluation of Activation of a NCI National Clinical Trials Network (NCTN) Study S1826 for Hodgkin Lymphoma (HL) at Children's Oncology Group (COG) Institutions

Sharon M. Castellino, MD MSc, Angela Punnett, MD, Susan K Parsons, MD MRP, Nicholas P. DeGroote, MPH, Sally Muehle, Hongli Li, MS, Michael E. Roth, MD, Alex F. Herrera, MD, Jonathan W. Friedberg, MD MSSc, Nita L. Seibel, MD, Kara M. Kelly, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20.
https://doi.org/10.1182/blood-2020-134738
Published: 2020
Journal Articles

Prenatal Hemoglobinopathy Screening Practices: Areas for Improvement

Scott Moerdler, MD, Ellen Fraint, MD, Ellen Silver, PhD, Siobhan M Dolan, MD, M.P.H., Kafui A Demasio, MD, M.P.H., Michael E. Roth, MD, Deepa Manwani, MD, Kerry A Morrone, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2298.
https://doi.org/10.1182/blood-2019-126084
Published: 2019
Journal Articles

Utilization of a Pediatric Sickle Cell Day Hospital By Patients with Sickle Cell Disease and Pain Events Is Associated with a Lower Rate of Inpatient Hospital Admission Compared to Utilization of the Pediatric Emergency Department

Rochelle Maxwell, MD, Veronika Polishchuk, MD, Jeremy Rosenblum, M. Catherine Driscoll, MD, Kerry A Morrone, MD, Jonathan B. Gill, MD, Michael E. Roth, MD, Deepa Manwani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4643.
https://doi.org/10.1182/blood.V130.Suppl_1.4643.4643
Published: 2017